16 / NIVOLUMAB AS 2ND LINE THERAPY IN PATIENTS (PTS) WITH METASTATIC NON SMALL CELL LUNG CANCER (MNSCLC)

Autor:	Theodoros Tegos
Rok vydání:	2018
DOI:	10.26226/morressier.5afadd89f314ac000849afa2
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::68c1481ad849ca64713d71784ea42d4d https://doi.org/10.26226/morressier.5afadd89f314ac000849afa2 Zobrazit plný text záznamu